Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rod Jackson

Showing results (51-60 of 194) with videos related to

Pageof 20
Sort By:
Heart (British Cardiac Society)|April 29, 2010
'Your Heart Forecast': a new approach for describing and communicating cardiovascular risk?Susan Wells, Andrew Kerr, Stewart Eadie, et al.
The New Zealand Medical Journal|October 14, 2016
The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage studySuneela Mehta, Sue Wells, Rod Jackson, et al.
The New Zealand Medical Journal|October 26, 2018
Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease?Vanessa Selak, Rod Jackson, Katrina Poppe, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 9, 2008
Quantifying the effect of age on short-term and long-term case fatality in 14,000 patients with incident cases of cardiovascular diseaseRoger J Marshall, Richard J Milne, Robert Lynn, et al.
The New Zealand Medical Journal|December 6, 2006
Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1)Lot Bannink, Susan Wells, Joanna Broad, et al.
The New Zealand Medical Journal|October 6, 2017
An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisionsThomas Robinson, Rod Jackson, Susan Wells, et al.
European Heart Journal Open|May 13, 2026
Population-level cardiovascular risk prediction models including biochemical predictors in 800 000 individualsBruno Batinica, Suneela Mehta, Jingyuan Liang, et al.
Australian and New Zealand Journal of Public Health|April 13, 2018
Constructing whole of population cohorts for health and social research using the New Zealand Integrated Data InfrastructureJinfeng Zhao, Sheree Gibb, Rod Jackson, et al.
The New Zealand Medical Journal|September 18, 2008
Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitusPatricia A Metcalf, Susan Wells, Robert K R Scragg, et al.
The New Zealand Medical Journal|April 22, 2005
The burden of death, disease, and disability due to alcohol in New ZealandJennie Connor, Joanna Broad, Jürgen Rehm, et al.
Pageof 20

Showing results (51-60 of 194) with videos related to

Sort By:
Pageof 20
Heart (British Cardiac Society)|April 29, 2010
'Your Heart Forecast': a new approach for describing and communicating cardiovascular risk?Susan Wells, Andrew Kerr, Stewart Eadie, et al.
The New Zealand Medical Journal|October 14, 2016
The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage studySuneela Mehta, Sue Wells, Rod Jackson, et al.
The New Zealand Medical Journal|October 26, 2018
Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease?Vanessa Selak, Rod Jackson, Katrina Poppe, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 9, 2008
Quantifying the effect of age on short-term and long-term case fatality in 14,000 patients with incident cases of cardiovascular diseaseRoger J Marshall, Richard J Milne, Robert Lynn, et al.
The New Zealand Medical Journal|December 6, 2006
Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1)Lot Bannink, Susan Wells, Joanna Broad, et al.
The New Zealand Medical Journal|October 6, 2017
An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisionsThomas Robinson, Rod Jackson, Susan Wells, et al.
European Heart Journal Open|May 13, 2026
Population-level cardiovascular risk prediction models including biochemical predictors in 800 000 individualsBruno Batinica, Suneela Mehta, Jingyuan Liang, et al.
Australian and New Zealand Journal of Public Health|April 13, 2018
Constructing whole of population cohorts for health and social research using the New Zealand Integrated Data InfrastructureJinfeng Zhao, Sheree Gibb, Rod Jackson, et al.
The New Zealand Medical Journal|September 18, 2008
Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitusPatricia A Metcalf, Susan Wells, Robert K R Scragg, et al.
The New Zealand Medical Journal|April 22, 2005
The burden of death, disease, and disability due to alcohol in New ZealandJennie Connor, Joanna Broad, Jürgen Rehm, et al.
Pageof 20